Click Therapeutics Secures $30M in Growth Capital from K2 HealthVentures to Expand Operations (press release):
Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ solutions as prescription medical treatments, today announced $30 million in debt financing from K2 HealthVentures (K2HV), a healthcare-focused specialty finance company, to accelerate commercialization of its leading smoking cessation solution, Clickotine™, and to advance its pipeline of clinically-validated digital therapeutics [Read more…] about Click Therapeutics raises $30 million in debt to advance commercialization of smoking cessation app Clickotine